OAC
EBS icon

OMERS Administration Corp’s Emergent Biosolutions EBS Stock Holding History

OMERS Administration Corp’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,700
Closed -$130K – 1135
2025
Q3 		$130K Buy
+14,700
New +$114K ﹤0.01% 1025
2025
Q2 		– Sell
-146,700
Closed -$713K – 933
2025
Q1 		$713K Buy
146,700
+114,500
+356% +$948K 0.01% 642
2024
Q4 		$308K Buy
+32,200
New +$295K ﹤0.01% 815

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OMERS Administration Corp's EBS Position: Q4 2025 in Review

OMERS Administration Corp sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 14,700 shares — an estimated $130K sold.

OMERS Administration Corp first reported a position in EBS in Q4 2024 and held it in 3 quarters. The position peaked at $713K in Q1 2025. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • OMERS Administration Corp reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 14,700 Emergent Biosolutions shares in Q4 2025, an estimated $130K.
  • OMERS Administration Corp first reported a position in Emergent Biosolutions in Q4 2024 and held it in 3 quarters.
  • OMERS Administration Corp's Emergent Biosolutions position peaked at $713K in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.